GRECO-2: A Randomized, Phase 2 Study of Stereotactic Body Radiation Therapy (SBRT) in Combination with GC4711 in the Treatment of Unresectable or Borderline Resectable Nonmetastatic Pancreatic Cancer (PC).

International journal of radiation oncology, biology, physics(2021)

引用 2|浏览4
暂无评分
摘要
GC4711 may improve the benefit-risk ratio of 5-fraction SBRT and drive survival benefit of local treatment of chemotherapy responsive PC patients.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要